Peter Speyer

Peter is Head of Data & Analytics at the Novartis Foundation, accelerating the use of data and analytics in support of the Foundation's mission to improve population health and reduce inequities. Previously, Peter co-founded Novartis AG's transformative data42 programme, which enables the use of the company's extensive preclinical, clinical and real-world data to accelerate and improve drug discovery.

Prior to Novartis, Peter was Chief Data & Technology Officer at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle. He managed data for the Global Burden of Disease (GBD) study and created IHME's global public data catalogue, the Global Health Data Exchange (GHDx), and innovative interactive data visualisations.